Designated Drug Use Investigation 1 of Follistim Injection.

Trial Profile

Designated Drug Use Investigation 1 of Follistim Injection.

Completed
Phase of Trial: Phase III

Latest Information Update: 02 May 2014

At a glance

  • Drugs Follitropin beta (Primary)
  • Indications Infertility
  • Focus Therapeutic Use
  • Sponsors Organon; Schering-Plough
  • Most Recent Events

    • 07 Oct 2009 Trial sponsor changed from 'Organon' to 'Schering-Plough' as reported by ClinicalTrials.gov.
    • 23 Jun 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top